[Ovid] Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause [A132]

lailascience1 Post time 2024-5-24 18:40:52 | Show all posts |Read mode
Reward20points

journal:Obstetrics & Gynecology

Authors:Samuel Lederman; Marla Shapiro CM; Petra Stute; Misun Lee; Xuegong Wang; Genevieve Neal-Perry

Published date:2022-5-

DOI:10.1097/01.aog.0000825808.38519.3b

PDF link:https://journals.lww.com/10.1097/01.AOG.0000825808.38519.3b

Article link:http://dx.doi.org/10.1097/01.aog.0000825808.38519.3b

Article Source:Ovid Technologies (Wolters Kluwer Health)


Remark:

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
fernandoribeiro Post time 2024-5-24 18:40:53 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    3915

Latest Reply

Return to the list